Kiora Pharmaceuticals, Inc.
KPRX
$2.55
-$0.04-1.54%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 57.39% | -0.60% | -18.65% | -0.23% | -62.12% |
| Gross Profit | -57.39% | 0.60% | 18.65% | -2.02% | -103.90% |
| SG&A Expenses | 8.25% | 9.88% | 4.55% | -11.97% | 14.89% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 21.78% | 4.95% | -6.77% | -7.62% | -26.34% |
| Operating Income | -21.78% | -4.95% | 6.77% | 6.86% | -115.56% |
| Income Before Tax | -16.81% | -232.01% | 81.94% | -1.93% | -115.39% |
| Income Tax Expenses | -- | -131.48% | -- | -- | -- |
| Earnings from Continuing Operations | -10.26% | -54.29% | 100.79% | 3.11% | -116.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.26% | -54.29% | 100.79% | 3.11% | -116.30% |
| EBIT | -21.78% | -4.95% | 6.77% | 6.86% | -115.56% |
| EBITDA | -21.29% | -4.78% | 7.09% | 6.75% | -115.55% |
| EPS Basic | -11.38% | -56.07% | 100.77% | -1.30% | -111.14% |
| Normalized Basic EPS | -35.68% | -26.30% | 8.49% | -5.81% | -109.12% |
| EPS Diluted | -11.54% | -56.02% | 100.77% | -1.37% | -115.03% |
| Normalized Diluted EPS | -35.68% | -26.30% | 10.00% | -5.81% | -112.32% |
| Average Basic Shares Outstanding | -1.00% | -1.14% | 1.78% | -4.35% | 46.33% |
| Average Diluted Shares Outstanding | -1.00% | -1.14% | 3.48% | -4.35% | 8.36% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |